Jordan Bleznick, Director at ENZON PHARMACEUTICALS, INC. (ENZN), bought 100,000 shares at $0.15 ($15K) on 2020-11-13, disclosed to the SEC on 2020-11-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.